1.Yancy, CW, Jessup, M, Bozkurt, B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013; 128(16):e240–e327.
2.Liu, L, Eisen, HJ. Epidemiology of heart failure and scope of the problem. Cardiol Clin. 2014; 32(1):1–8, vii.
3.Holdright, DR, Dayer, M, Cowie, MR. Heart failure: diagnosis and healthcare burden. Clin Med. 2004; 4(1):13–18.
4.Wong, CY, Chaudhry, SI, Desai, MM, Krumholz, HM. Trends in comorbidity, disability, and polypharmacy in heart failure. Am J Med. 2011; 124(2):136–143.
5.Levy, D, Kenchaiah, S, Larson, MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002; 347(18):1397–1402.
6.Upshaw, J, Kiernan, MS. Preoperative cardiac risk assessment for noncardiac surgery in patients with heart failure. Curr Heart Fail Rep. 2013; 10(2):147–156.
7.Swedberg, K, Cleland, J, Cowie, MR, et al. Successful treatment of heart failure with devices requires collaboration. Eur J Heart Fail. 2008; 10(12):1229–1235.
8.Bardia, A, Montealegre-Gallegos, M, Mahmood, F, et al. Left atrial size: an underappreciated perioperative cardiac risk factor. J Cardiothor Vasc Anesth. 2014; 28(6):1624–1632.
9.Taylor, AL. Heart failure in women. Curr Heart Fail Rep. 2015; 12(2):187–195.
10.Taylor, T. Emergency Ultrasound Guidelines. 2010:1–38.
11.Roger, VL, Weston, SA, Redfield, MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004; 292(3):344–350.
12.Matyal, R. Newly appreciated pathophysiology of ischemic heart disease in women mandates changes in perioperative management: a core review. Anesth Analg. 2008; 107(1):37–50.
13.Meyer, S, van der Meer, P, Massie, BM, et al. Sex-specific acute heart failure phenotypes and outcomes from PROTECT. Eur J Heart Fail. 2013; 15(12):1374–1381.
14.Sharkey, SW, Lesser, JR, Zenovich, AG, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation. 2005; 111(4):472–479.
15.Akashi, YJ, Goldstein, DS, Barbaro, G, Ueyama, T. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation. 2008; 118(25):2754–2762.
16.Cowie, MR, Wood, DA, Coats, AJ, et al. Incidence and aetiology of heart failure: a population-based study. Eur Heart J. 1999; 20(6):421–428.
17.Dolgin, M. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. New York, Little, Brown Medical Division; 1994.
18.Hunt, SA, Abraham, WT, Chin, MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009; 53(15):e1–e90.
19.Takeishi, Y. Biomarkers in heart failure. Int Heart J. 2014; 55(6):474–481.
20.Farmakis, D, Parissis, J, Lekakis, J, Filippatos, G. Acute heart failure: epidemiology, risk factors, and prevention. Rev Esp Cardiol (Engl Ed). 2015; 68(3):245–248.
21.Schocken, DD, Benjamin, EJ, Fonarow, GC, et al. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2008; 117(19):2544–2565.
22.Poldermans, D, Bax, JJ, Boersma, E, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J. 2009; 30(22):2769–2812.
23.Garbade, J, Barten, MJ, Bittner, HB, Mohr, FW. Heart transplantation and left ventricular assist device therapy: two comparable options in end-stage heart failure? Clin Cardiol. 2013; 36(7):378–382.
24.Rose, EA, Gelijns, AC, Moskowitz, AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001; 345(20):1435–1443.
25.Slaughter, MS, Rogers, JG, Milano, CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009; 361(23):2241–2251.
26.Rathore, SS, Curtis, JP, Wang, Y, Bristow, MR, Krumholz, HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA. 2003; 289(7):871–878.
27.Simon, T, Mary-Krause, M, Funck-Brentano, C, Jaillon, P. Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation. 2001; 103(3):375–380.
28.Modena, MG, Muia, N, Aveta, P, Molinari, R, Rossi, R. Effects of transdermal 17beta-estradiol on left ventricular anatomy and performance in hypertensive women. Hypertension. 1999; 34(5):1041–1046.
29.Rossouw, JE, Prentice, RL, Manson, JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007; 297(13):1465–1477.
30.Hernandez, AF, Whellan, DJ, Stroud, S, et al. Outcomes in heart failure patients after major noncardiac surgery. J Am Coll Cardiol. 2004; 44(7):1446–1453.
31.Healy, KO, Waksmonski, CA, Altman, RK, et al. Perioperative outcome and long-term mortality for heart failure patients undergoing intermediate- and high-risk noncardiac surgery: impact of left ventricular ejection fraction. Congest Heart Fail. 2010; 16(2):45–49.
32.Stoelting, RK, Dierdorf, SF, McCammon, RL. Anesthesia and Co-Existing Disease. London, Churchill Livingston, 2002.